Sign up
Healthed-White-on-Blue
Emerging young leaders in the TRF building for the 2020 Hudson Institute Annual Report. PICTURE : PENNY STEPHENS, 73 STORIES. MONDAY 17TH FEBRUARY 2020

A/Prof Jun Yang

Research Scientist, Endocrine Hypertension Group at Hudson Institute; Consultant Endocrinologist, Monash Health; Senior Postdoctoral Fellow, Department of Medicine, School of Clinical Sciences at Monash Health
A/Prof Yang is an endocrine hypertension researcher and clinician who has demonstrated the high prevalence of Primary Aldosteronism (PA) in the community and is now leading research to enable early diagnosis and treatment of this condition.

One in 10 patients with hypertension have PA but it is often misdiagnosed as conventional hypertension – less than one in 100 patients are diagnosed correctly. As a result, patients are given the wrong treatment and suffer preventable heart disease or stroke. PA is a form of high blood pressure caused by overactive adrenal glands that make too much aldosterone, a salt-retaining hormone, which leads to high blood pressure as well as heart and kidney damage. Correctly diagnosed, PA and the consequent hypertension can be treated or cured with surgery.

Over a 10-year period (2010-2020) A/Prof Yang has developed diagnostic and management guidelines for primary aldosteronism at Monash Health that has led to a 40-fold increase in the number of patients diagnosed.

In 2016, A/Prof Yang established the first dedicated Endocrine Hypertension Service in Victoria, integrating medical research findings into clinical practice. She is currently leading national and international efforts to streamline the diagnosis and management of PA, including leading a network of researchers to formulate problem solving strategies across Australia.

A/Prof Yang has been awarded more than $8 million in grant funding from National government agencies (MRFF and NHRMC), as well as philanthropic bodies including the Heart Foundation and Rebecca Cooper Foundation.

A/Prof Yang contributes to the Endocrine Society of Australia as the Co-Chair of its Annual Scientific Meeting (2023-2025); and the Endocrine Society (US) as a member of its Annual Meeting Steering Committee (2024-2026).

“My main interest lies in the translation of primary aldosteronism research into revised clinical guidelines, improved diagnostic tools and transformed practice to help patients. In addition, I am identifying the earliest point of disease occurrence with the aim of enabling earlier intervention and return to health.”

More from this expert

Primary aldosteronism_J Yang_CT_Feature_Image

Resistant “essential” hypertension: Could it be primary aldosteronism?

A/Prof Jun Yang discusses primary aldosteronism (PA) as a common yet under-recognised cause of hypertension, particularly in resistant cases

By A/Prof Jun Yang
Podcasts iconPodcasts

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.

Register for webcast